Yong Man Kim
Net worth: 56 200 $ as of 2024-04-29
Profile
Dr. Yong Man Kim is a Chief Scientific Officer & Director at NKMAX Co., Ltd.
and a Director & Chief Scientific Officer at NKGen Biotech, Inc. He is on the Board of Directors at NKMAX Co., Ltd.
and NKGen Biotech, Inc. Dr. Kim was previously employed as a Chief Scientific & Innovation Officer by NKGen Biotech, Inc. /US/ and a Research Professor by Wonkwang University.
He received his doctorate degree from Chungnam National University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.12% | 2024-04-28 | 28,384 ( 0.12% ) | 56 200 $ | 2024-04-29 |
Yong Man Kim active positions
| Companies | Position | Start |
|---|---|---|
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Chief Tech/Sci/R&D Officer | 2017-08-31 |
Former positions of Yong Man Kim
| Companies | Position | End |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Chief Tech/Sci/R&D Officer | 2023-08-31 |
| Wonkwang University | Corporate Officer/Principal | - |
Training of Yong Man Kim
| Chungnam National University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Stock Market
- Insiders
- Yong Man Kim
